Testing a new tablet in healthy adults
Part of Immune system & allergy, Skin clinical trials.
This study tests a new medication called HL40626S to see if it is safe in healthy adults. You would take the tablet and have regular checkups to monitor how your body responds.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You are in good general health.
- Your body mass index (BMI) is between 18 and 32.
- You weigh at least 50 kg (about 110 pounds).
- If you are female, you are not pregnant or breastfeeding.
- You agree to use effective birth control or abstain from sexual activity that could lead to pregnancy during the study and for 90 days after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This study tests a new investigational tablet in healthy adults to see how the body handles it and if it's safe. The results will help guide future research.
This early-phase study tests an experimental oral tablet (UA026) in people with moderate to severe plaque psoriasis. The purpose is to see how safe and effective the drug is, and how it works in the body.
This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.
This study tests a new investigational drug called ISH0613 in healthy volunteers to see if it is safe and how the body processes it. It is the first time this drug is given to humans.
This trial studies an investigational medicine called HRS-4139 in healthy adults. The purpose is to see how safe it is, how the body processes it, and how it affects the immune system.
Hear when a new Psoriasis (PsO) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.